Estimates Revisions DexCom, Inc.
Stocks
DXCM
US2521311074
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
After hours 08:00:00 pm | |||
| 87.31 USD | +4.63% |
|
83.64 | -4.20% |
| Aug. 03 | UBS Adjusts Price Target on DexCom to $102 From $96, Maintains Buy Rating | MT |
| Aug. 03 | Rothschild & Co Redburn Adjusts Price Target on DexCom to $100 From $90, Maintains Buy Rating | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- DXCM Stock
- Consensus DexCom, Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
